Summit Creek Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Sell
120,354
-68,783
-36% -$1.92M 0.92% 48
2026
Q1
$6.93M Buy
189,137
+48,264
+34% +$1.9M 1.42% 37
2025
Q4
$6.43M Buy
+140,873
New +$6.27M 1.01% 48

Other funds holding AORT

Summit Creek Advisors's AORT Position: Q2 2026 in Review

Summit Creek Advisors reduced its Artivion (AORT) stake by 36% in Q2 2026, selling an estimated $1.92M and leaving 120,354 shares worth $2.7M. The position accounts for 0.92% of the portfolio, ranked #48.

Summit Creek Advisors first reported a position in AORT in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.93M in Q1 2026. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Summit Creek Advisors held 120,354 shares of Artivion worth $2.7M as of Q2 2026.
  • Summit Creek Advisors sold 68,783 Artivion shares in Q2 2026, an estimated $1.92M.
  • Artivion made up 0.92% of Summit Creek Advisors's portfolio in Q2 2026, its #48 holding.
  • Summit Creek Advisors first reported a position in Artivion in Q4 2025 and has held it in 3 quarters since.
  • Summit Creek Advisors's Artivion position peaked at $6.93M in Q1 2026.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Summit Creek Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.